New codes for reimbursement of medical telemonitoring activities introduced in France

On July 05, 2023, the new version of the List of reimbursable products and services (LPPR) was released. The following codes for reimbursement of digital medical devices used for medical telemonitoring activities (DMN-TSM) were registered in generic form in the Chapter 1, sub-chapter 6 of the List of reimbursable products and services (LPPR):

• 1668102 - DMN-TSM, chronic kidney failure, dialysis, transplant, monthly package;
• 1659468 - DMN-TSM, respiratory failure, adult patient, monthly package;
• 1612544 - DMN-TSM, chronic heart failure, monthly package;
• 1654962 - DMN-TSM, Type 1 and Type 2 diabetes on insulin, monthly package;
• 1694358 - DMN-TSM, gestational diabetes on insulin, monthly package.

As the reimbursement codes presented here provide an organizational benefit, their tariff is €50 per patient per month. More details regarding the tariffs for medical telemonitoring activities were provided in the Order of the Ministry of Health and Prevention on May 16, 2023 (already reported by MTRC here).

The registration of these codes in the LPPR is based on the four Orders of the Ministry of Health and Prevention on the inclusion of five medical telemonitoring activities relating to kidney failure, respiratory failure, heart failure, and diabetes. The Orders provide additional information, such as the reimbursed indications, minimum technical specifications for digital medical devices, minimum requirements applicable to the medical telemonitoring operator, terms of prescription, use, distribution of digital medical devices, and registration conditions.

The Orders are effective from July 1, 2023.

See the details in French here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.